Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
Medically reviewed by Drugs.com
via HealthDayMONDAY, May 11, 2026 — The relationship between depression and age-related brain decline might depend on a person’s history with the mood disorder, a new study says.
Researchers had thought that people experiencing “brain fog” from aging might be more apt to relapse into depression.
But they found the opposite was true – people with sharper brains were more likely to fall back into depression, according to findings published May 6 in the journal BMJ Mental Health.
“People often think of memory problems as simply a consequence of depression, but our findings suggest the relationship is more complex,” senior researcher Dr. Anya Topiwala, a consultant psychiatrist at the University of Oxford in the U.K., said in a news release.
“Among people with a history of depression, those with better cognitive performance were actually more likely to experience future depressive symptoms,” Topiwala said.
On the other hand, people who’d never had depression were more likely to have their first bout if their cognitive scores were lower, researchers found.
Declines in memory, attention and other brain functions affect as many as 90% of people with major depression, and 40% of people with depression have persistent brain impairment, researchers said in background notes.
For the study, researchers tracked nearly 1,900 U.K. residents with a history of depression, matching them to an equal number of people who’d never had depression. All the participants underwent cognitive tests and MRI scans to check their brain health.
Overall, people who’d previously had depression had almost three times higher risk of suffering a relapse than those having their first bout of depression – 33% versus 13% during years of follow-up.
Results showed that depression patients who performed worst on cognitive tests were less likely to relapse compared to those with the best brain function.
This was contrary to what was seen in people without a history of depression, where worse performance on brain tests was linked to a higher risk of depression. Low cognitive scores increased their risk of a first bout of depression by 40%, researchers found.
“We expected poorer cognitive performance to be associated with a higher risk of future depression in both participants with a history of depression and matched controls; however, the results were more nuanced than expected,” lead researcher Angharad de Cates, a clinical lecturer at the University of Birmingham, said in a news release.
"Among people with previous depression, those with higher cognitive scores were more likely to experience a further depressive episode than those with lower scores — the opposite pattern to that observed in controls,” she said.
This might be because those with impaired brain function might not be able to understand what’s happening to them, de Cates said.
“One possible explanation is that better cognitive functioning may be needed to recognize symptoms and seek help, highlighting the importance of optimizing cognition in those with previous depression to support early intervention,” she said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-11 21:41
Read more
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Datopotamab Deruxtecan Improves Survival in Triple-Negative Breast Cancer
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
- Online Program Soothes Post-Trauma Stress In Injured Children
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions